Key facts
- It has raised $200K; the latest was Early Stage VC ($200K) in Jul 2025.
- Notable investors include Big Idea Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Darewin Evolution
- ·The full record, as it builds
Funding rounds
No funding rounds for Darewin Evolution are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Darewin Evolution
Developer of microalgae-productivity enhancement technology intended for raising yields of omega-3. The company's platform uses AI-driven Darwinian selection methods applied to strains of marine microalgae, dynamic screening for growth performance, process optimization under controlled conditions, and improvements in strain robustness, enabling nutrition, food-ingredient, and health industries to access higher-productivity algal biomass, reduce production costs, and support a more scalable, sustainable supply of omega-3s and similar molecules.
- Sector
- Healthcare
- HQ
- Villefranche-sur-Mer, France
- Founded
- 2024
- Employees
- 3
- Website
- darewinevolution.com/
- Ownership
- Privately Held (backing)
Darewin Evolution doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Darewin Evolution shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Darewin Evolution in its N-PORT filings yet. We sweep new filings monthly.